مؤسسه تحقیقات همه‌گیرشناسی و میکروبیولوژی گامالیا (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "مؤسسه تحقیقات همه‌گیرشناسی و میکروبیولوژی گامالیا" in Persian language version.

refsWebsite

Global rank Persian rank

5nih.gov

4^th place

5^th place

4doi.org

2^nd place

2firstpost.com

283^rd place

653^rd place

2worldcat.org

5^th place

12^th place

1saw-leipzig.de

low place

1gamaleya.org

low place

1tass.com

1,763^rd place

1,604^th place

1xinhuanet.com

309^th place

1,060^th place

1who.int

195^th place

129^th place

1dailysabah.com

2,228^th place

2,162^nd place

1ft.com

210^th place

393^rd place

1outlookindia.com

526^th place

1,838^th place

1nature.com

234^th place

262^nd place

1sciencemag.org

857^th place

630^th place

1reuters.com

49^th place

76^th place

1thelancet.com

2,393^rd place

5,046^th place

1cnbc.com

220^th place

283^rd place

cnbc.com (Global: 220^th place; Persian: 283^rd place)

Holly Ellyatt (2020-09-10). "Scientists question 'strange' data in Russian coronavirus vaccine trial after 'unlikely' patterns". CNBC. Retrieved 2020-09-10.

dailysabah.com (Global: 2,228^th place; Persian: 2,162^nd place)

"Russia plans to start producing coronavirus vaccine in September" (به انگلیسی). Daily Sabah. 2020-08-11. Retrieved 10 August 2020.

doi.org (Global: 2^nd place; Persian: 2^nd place)

Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, et al. (2017-02-02). "Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia". Human Vaccines and Immunotherapeutics. 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMC 5360131. PMID 28152326.
Callaway, Ewen (11 August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature (به انگلیسی). 584 (7821): 334–335. doi:10.1038/d41586-020-02386-2. PMID 32782400. Retrieved 11 August 2020. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.
Logunov, Denis Y; Dolzhikova, Inna V; et al. (2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". The Lancet. 396 (10255): 887–897. doi:10.1016/s0140-6736(20)31866-3. ISSN 0140-6736. PMC 7471804. PMID 32896291.
Logunov, Denis Y; et al. "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia". The Lancet. doi:10.1016/S0140-6736(21)00234-8.

firstpost.com (Global: 283^rd place; Persian: 653^rd place)

"Russia's COVID-19 vaccine successfully completes first phase of human clinical trials - Health News, Firstpost". Firstpost. 2020-07-13. Retrieved 2020-08-11.
"Putin announces first 'registered' COVID-19 vaccine from Russia's Gamaleya Institute; his daughter among those inoculated - Health News, Firstpost". Firstpost. 2020-08-11. Retrieved 2020-08-11.

ft.com (Global: 210^th place; Persian: 393^rd place)

Foy, Henry (22 July 2020). "Russia races for vaccine as Covid-19 nonchalance spreads". www.ft.com. Retrieved 2020-08-16.

gamaleya.org (Global: low place; Persian: low place)

"1891 г.[: Частный химико-микроскопический и бактериологический кабинет Ф. М. Блюменталя."]

nature.com (Global: 234^th place; Persian: 262^nd place)

Callaway, Ewen (11 August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature (به انگلیسی). 584 (7821): 334–335. doi:10.1038/d41586-020-02386-2. PMID 32782400. Retrieved 11 August 2020. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.

nih.gov (Global: 4^th place; Persian: 5^th place)

pubmed.ncbi.nlm.nih.gov

Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, et al. (2017-02-02). "Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia". Human Vaccines and Immunotherapeutics. 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMC 5360131. PMID 28152326.
Callaway, Ewen (11 August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature (به انگلیسی). 584 (7821): 334–335. doi:10.1038/d41586-020-02386-2. PMID 32782400. Retrieved 11 August 2020. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.
Logunov, Denis Y; Dolzhikova, Inna V; et al. (2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". The Lancet. 396 (10255): 887–897. doi:10.1016/s0140-6736(20)31866-3. ISSN 0140-6736. PMC 7471804. PMID 32896291.

ncbi.nlm.nih.gov

Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, et al. (2017-02-02). "Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia". Human Vaccines and Immunotherapeutics. 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMC 5360131. PMID 28152326.
Logunov, Denis Y; Dolzhikova, Inna V; et al. (2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". The Lancet. 396 (10255): 887–897. doi:10.1016/s0140-6736(20)31866-3. ISSN 0140-6736. PMC 7471804. PMID 32896291.

outlookindia.com (Global: 526^th place; Persian: 1,838^th place)

"Russian University Says It Has Finished Human Trials For Covid-19 Vaccine". Retrieved 2020-08-11.

reuters.com (Global: 49^th place; Persian: 76^th place)

Kate Kelland (11 August 2020). "Scientists ask: Without trial data, how can we trust Russia's COVID vaccine?". Reuters (به انگلیسی). Retrieved 11 August 2020.

saw-leipzig.de (Global: low place; Persian: low place)

drw.saw-leipzig.de

http://drw.saw-leipzig.de/31229 - "BLJUMENTAL', Filipp Markovič [...] 1891-1917 [:] Gründer und Direktor des privaten „Chemisch-Mikroskopischen und Bakteriologischen Kabinetts“ bzw. „Chemisch-Bakteriologischen Instituts von Dr. Philipp Blumenthal“ [...] in Moskau [...]."

sciencemag.org (Global: 857^th place; Persian: 630^th place)

Cohen, Jon (11 August 2020). "Russia's approval of a COVID-19 vaccine is less than meets the press release". Science. Retrieved 13 August 2020.

tass.com (Global: 1,763^rd place; Persian: 1,604^th place)

"COVID-19 vaccines by Gamaleya Center, Vektor are most promising". TASS. Retrieved 2020-08-11.

thelancet.com (Global: 2,393^rd place; Persian: 5,046^th place)

Logunov, Denis Y; Dolzhikova, Inna V; et al. (2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". The Lancet. 396 (10255): 887–897. doi:10.1016/s0140-6736(20)31866-3. ISSN 0140-6736. PMC 7471804. PMID 32896291.

who.int (Global: 195^th place; Persian: 129^th place)

"WHO prequalifies Ebola vaccine, paving the way for its use in high-risk countries". World Health Organization. 12 November 2019. Retrieved 15 August 2020.

worldcat.org (Global: 5^th place; Persian: 12^th place)

Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, et al. (2017-02-02). "Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia". Human Vaccines and Immunotherapeutics. 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMC 5360131. PMID 28152326.
Logunov, Denis Y; Dolzhikova, Inna V; et al. (2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". The Lancet. 396 (10255): 887–897. doi:10.1016/s0140-6736(20)31866-3. ISSN 0140-6736. PMC 7471804. PMID 32896291.

xinhuanet.com (Global: 309^th place; Persian: 1,060^th place)

news.xinhuanet.com

"Russia to deliver Ebola vaccines to Guinea by end of June". Xinhua, New China. 18 May 2017. Retrieved 11 August 2020.

مؤسسه تحقیقات همه‌گیرشناسی و میکروبیولوژی گامالیا (Persian Wikipedia)

cnbc.com (Global: 220th place; Persian: 283rd place)

dailysabah.com (Global: 2,228th place; Persian: 2,162nd place)

doi.org (Global: 2nd place; Persian: 2nd place)

firstpost.com (Global: 283rd place; Persian: 653rd place)

ft.com (Global: 210th place; Persian: 393rd place)

gamaleya.org (Global: low place; Persian: low place)

nature.com (Global: 234th place; Persian: 262nd place)

nih.gov (Global: 4th place; Persian: 5th place)